Durable virological response and functional cure of chronic hepatitis D after long‐term peginterferon therapy-Reference-Cited by-同舟云学术

Durable virological response and functional cure of chronic hepatitis D after long‐term peginterferon therapy

Published:2021-05-28 Issue:2 Volume:54 Page:176-182
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Hercun Julian¹^ORCID,Kim Grace E.¹,Da Ben L.¹,Rotman Yaron¹^ORCID,Kleiner David E.²,Chang Richard³,Glenn Jeffrey S.⁴,Hoofnagle Jay H.⁵,Koh Christopher¹^ORCID,Heller Theo¹

Affiliation:

1. Liver Diseases Branch National Institute of Diabetes and Digestive and Kidney Diseases National Institutes of Health Bethesda MD USA

2. Laboratory of Pathology National Cancer InstituteNational Institutes of Health Bethesda MD USA

3. Clinical Center National Institutes of Health Bethesda MD USA

4. Division of Gastroenterology and Hepatology Department of Medicine Stanford University School of Medicine Stanford CA USA

5. Liver Disease Research Branch National Institute of Diabetes and Digestive and Kidney Diseases National Institutes of Health Bethesda MD USA

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.16408

Reference23 articles.

1. Hepatitis Delta

2. The global prevalence of hepatitis D virus infection: Systematic review and meta-analysis

3. Long-term therapy of chronic delta hepatitis with peginterferon alfa

4. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection

5. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances and Challenges in Managing Hepatitis D Virus: Evolving Strategies;Current Hepatology Reports;2024-02-01

2. Antiviral Therapy of Chronic Hepatitis D Virus Infection – Addendum to the S3 Guideline “Prophylaxis, Diagnosis and Therapy of Hepatitis B Virus Infection” of the German Society for Gastroenterology, Digestive and Metabolic Diseases (DGVS);Zeitschrift für Gastroenterologie;2023-12

3. Addendum „Antivirale Therapie der chronischen Hepatitis-D-Virusinfektion“ zur S3-Leitlinie „Prophylaxe, Diagnostik und Therapie der Hepatitis-B-Virusinfektion“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS);Zeitschrift für Gastroenterologie;2023-12

4. EASL Clinical Practice Guidelines on hepatitis delta virus;Journal of Hepatology;2023-08

5. Chronic hepatitis delta cirrhosis cured by adapting PEG-IFNα-2a + tenofovir disoproxil fumarate treatment duration until HBsAg loss;Clinics and Research in Hepatology and Gastroenterology;2023-08